Amphastar Pharmaceuticals (AMPH) Intangibles (2013 - 2026)

Amphastar Pharmaceuticals has reported Intangibles for 14 years, with the latest figure at $29.2 million in Q2 2026.

• On a quarterly basis, Intangibles changed 0.0% year-over-year to $29.2 million in Q2 2026; TTM through Jun 2026 was $29.2 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $29.2 million, changed 0.09% from the prior year.
• Intangibles was $29.2 million for Q2 2026 at Amphastar Pharmaceuticals, roughly flat from $29.2 million in the prior quarter.
• The five-year high for Intangibles was $29.2 million in Q1 2022, with the low at $29.2 million in Q4 2022.
• Average Intangibles over 5 years is $29.2 million, with a median of $29.2 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Intangibles changed 0.0% in 2022, then grew 0.09% in 2025.
• Over 5 years, Intangibles stood at $29.2 million in 2022, then changed by 0.0% to $29.2 million in 2023, then changed by 0.0% to $29.2 million in 2024, then advanced by 0.09% to $29.2 million in 2025, then changed by 0.0% to $29.2 million in 2026.
• The last three Intangibles figures came in at $29.2 million (Q2 2026), $29.2 million (Q1 2026), and $29.2 million (Q4 2025), per Business Quant data.